Endochondral Actin Focal ossification cytoskeleton adhesion VEGFA FGF2 COL11A1 ADAMTS4 FGFR1 COL3A1 PLAT4 TMSB4X COL4A1 COL10A1 GNA13 COL4A2 TGFB2 PDGFA COL4A4 PTHrP FGF1 COL5A1 FGF2 ENAH COL5A2 C4ST1 MSN COL1A1 FGFR1 GSN LAMC2 PDGFRB PDGFRB THBS2 COL1 KRAS CAV2 MRAS ARHGAP5 SOS2 PTEN AKT3 PDGFA PDGFC PGF ITGA2
PDGFRB RAP1B MAPK8 TGF[beta] MAPK signaling signaling Adipogenesis SMURF1 MAPK8 FOXO1A MAPK8 NGFB TRIB3 SKP1 PDGFRB PCK2 NEDD9 RASA2 EGR2 ETS1 SOS2 DDIT3 KLF11 KRAS GADD45A ATF3 MRAS GADD45B FOSB NF1 HIF1A SKIL RAP1B IRS1 SMURF1 DUSP1 MEF2D ZFYVE16 DDIT3 FAS HSPB1 SPOCK IL1A FAS TGFB2 MAP313 ZAK AKT3 MAP3K8 GADD45A Table 2: Genes involved in osteogenesis-related pathways that are downregulated in CYD-treated hMSCs.
ITGA2 was downregulated in the Npnt-coated group (0.86 [+ or -] 0.01-fold, p <0.01).
Additionally, mild attenuation of ITGA2 and ITGA6 expression was observed in the Npnt-treated group.
The quantitative mRNA expression of integrin [alpha]1 (ITGA1, (a)), [alpha]2 (ITGA2, (b)), [alpha]3 (ITGA3, (c)), [alpha]4 (ITGA4, (d)), [alpha]5 (ITGA5, (e)), [alpha]6 (ITGA6, (f)), [alpha]7 (ITGA7, (g)), [alpha]8 (ITGA8, (h)), [beta]1 (ITGB1, (i)), and [beta]3 (ITGB3, (j)) was determined by real-time RT-PCR.